Showing results (281-290 of 16,798) with videos related to

Sort By:
Pageof 1,680
British Journal of Haematology|August 17, 2019
GDF11 contributes to hepatic hepcidin (HAMP) inhibition through SMURF1-mediated BMP-SMAD signalling suppressionZheng Fang, Zesen Zhu, Haihang Zhang, et al.
British Journal of Haematology|August 20, 2019
JAK1/2 pathway inhibition suppresses M2 polarization and overcomes resistance of myeloma to lenalidomide by reducing TRIB1, MUC1, CD44, CXCL12, and CXCR4 expressionHaiming Chen, Mingjie Li, Eric Sanchez, et al.
British Journal of Haematology|October 1, 1988
Effects of preparative procedures and of cell activation on flow of white cells through micropore filtersG B Nash, J G Jones, J Mikita, et al.
British Journal of Haematology|October 2, 2019
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella studyRicardo García-Muñoz, Cristina Quero, Ernesto Pérez-Persona, et al.
British Journal of Haematology|October 7, 2019
High-throughput sequencing of T-cell receptor alpha chain clonal rearrangements at the DNA level in lymphoid malignanciesAlexander Komkov, Anna Miroshnichenkova, Gaiaz Nugmanov, et al.
British Journal of Haematology|May 1, 1985
Relationships between blood product exposure and immunological abnormalities in English haemophiliacsC A Lee, M Bofill, G Janossy, et al.
British Journal of Haematology|June 1, 1985
Cytogenetic studies on recipients of allogeneic bone marrow transplants after fractionated total body irradiationN Schmitz, E Gödde-Salz, H Löffler
British Journal of Haematology|March 2, 2019
Long-term overall- and progression-free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non-Hodgkin lymphomaTamer Khashab, Fredrick Hagemeister, Jorge E Romaguera, et al.
British Journal of Haematology|March 13, 2019
Sickle cell trait and renal disease among African American U.S. Army soldiersJiaqi Hu, D Alan Nelson, Patricia A Deuster, et al.
British Journal of Haematology|November 15, 2018
Circulating dendritic cells deficiencies as a new biomarker in classical Hodgkin lymphomaDomenico Galati, Serena Zanotta, Gaetano Corazzelli, et al.
Pageof 1,680